ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

FDA Approves Implanted Upper Airway Stimulation Device for Sleep Apnea

by Amy Eckner • July 1, 2014

  • Tweet
  • Email
Print-Friendly Version

In May, the U.S. Food and Drug Administration (FDA) approved a new surgical treatment option for use in patients with sleep apnea who do not respond well to traditional CPAP therapy.

You Might Also Like

  • Upper Airway Stimulation Effective for OSA in Patients with Prior Airway Surgery
  • Hypoglossal Nerve Stimulation May Be Effective in Obstructive Sleep Apnea
  • Obstructive Sleep Apnea Treatment Covered at Sleep Meeting
  • Sleep Apnea Associated with Hypertension in Young People

The Inspire Upper Airway Stimulation device uses three implanted components controlled through a small remote to provide mild stimulation to maintain an open airway. The device’s neurostimulation generator is implanted in the chest, with a lead that stimulates a nerve running from the ear to the jaw.

The main FDA clinical trial evaluated 126 patients over 12 months at 22 medical centers across the United States and Europe. Data from the trial were submitted to the FDA in 2013. Results were published in the Jan. 9 New England Journal of Medicine.

During the initial 12-month follow-up period, patients with the implanted system were found to have a significant reduction in apnea severity, reduced levels of snoring and a significant improvement in daytime functioning.

Eric J. Kezirian, MD, MPH, a professor of otolaryngology–head and neck surgery at the Keck School of Medicine of the University of Southern California in Los Angeles, believes that the device will prove beneficial for certain patients.

“Although the major study included patients with a relatively low body mass index compared to what we see in many sleep apnea patients,” he says, “I believe the difference between the response with other procedures and this device will actually be greater in patients with a somewhat-higher BMI.” He felt that there remains a role for other procedures, including for issues that may not respond to this device such as nasal blockage or large tonsils.

Kezirian also believes that the device will require close collaboration between surgeons and sleep medicine teams to be successful. “The procedure itself is only the first step in the process,” he cautions. “Sleep medicine teams should be able to deal with the nuances of the titration and the adjustments that will be required. The important thing is that for teams that take this on, the study results were pretty solid.”

Clinical Studies

Inspire’s device has been evaluated in five clinical studies:

  • Upper-airway stimulation for obstructive sleep apnea. Strollo PJ Jr, Soose RJ, Maurer JT, et al. N Engl J Med. 2014;370:139-149.
  • Evaluation of drug-induced sleep endoscopy as a patient selection tool for implanted upper airway stimulation for obstructive sleep apnea. Vanderveken OM, Maurer JT, Hohenhorst W, et al. J Clin Sleep Med. 2013;9:433-438.
  • Implanted upper airway stimulation device for obstructive sleep apnea. Van de Heyning PH, Badr MS, Baskin JZ, et al. Laryngoscope. 2012;122:1626-1633.
  • Therapeutic electrical stimulation of the hypoglossal nerve in obstructive sleep apnea. Schwartz AR, Bennett ML, Smith PL, et al. Arch Otolaryngol Head Neck Surg. 2001;127:1016-1023.

Pages: 1 2 | Multi-Page

Filed Under: Online Exclusives, Practice Focus, Sleep Medicine Tagged With: sleep, sleep apnea

You Might Also Like:

  • Upper Airway Stimulation Effective for OSA in Patients with Prior Airway Surgery
  • Hypoglossal Nerve Stimulation May Be Effective in Obstructive Sleep Apnea
  • Obstructive Sleep Apnea Treatment Covered at Sleep Meeting
  • Sleep Apnea Associated with Hypertension in Young People

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.